Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 194 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxy-3-hydroxypropyl-(R,S)-sulfonimidoyl]butanoic acid slow-binding, irreversible inactivation, ATP-dependent, a N-phosphorylated reaction intermediate is tightly bound to the enzyme, mechanism-based Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxy-3-phenylpropyl-(R,S)-sulfonimidoyl]butanoic acid weak, reversible inhibition Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxybutyl-(R,S)-sulfonimidoyl]butanoic acid slow-binding, irreversible inactivation, ATP-dependent, a N-phosphorylated reaction intermediate is tightly bound to the enzyme, mechanism-based Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxyhexyl-(R,S)-sulfonimidoyl]butanoic acid slow-binding, irreversible inactivation, ATP-dependent, a N-phosphorylated reaction intermediate is tightly bound to the enzyme, mechanism-based Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxyoctyl-(R,S)-sulfonimidoyl]butanoic acid weak, reversible inhibition Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[(2R,S)-2-carboxypropyl-(R,S)-sulfonimidoyl]butanoic acid slow-binding, irreversible inactivation, ATP-dependent, a N-phosphorylated reaction intermediate is tightly bound to the enzyme, mechanism-based Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.2(2S)-2-amino-4-[2-carboxyethyl-(R,S)-sulfonimidoyl]butanoic acid slow-binding, irreversible inactivation, ATP-dependent, a N-phosphorylated reaction intermediate is tightly bound to the enzyme, mechanism-based Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.22-mercaptoethanol - Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.24-hydroxy-2-nonenal treatment with 4-hydroxy-2-nonenal results in the dose-dependent adduction of both monomeric GCLC and GCLM. 4-Hydroxy-2-nonenal-mediated adduction of monomeric GCLC results in a dose-dependent increase in GCLC enzymatic activity. Treatment of GCL holoenzyme causes a dose-dependent decrease in GCL activity. 4-Hydroxy-2-nonenal-mediated inhibition of GCL holoenzyme activity is associated with a reduction in the levels of heterodimeric GCL holoenzyme complex due to increase in high molecular weight complexes. 4-Hydroxy-2-nonenal modification simultaneously activates monomeric GCLC activity and prevents its ability to heterodimerize with GCLM and form functional GCL holoenzyme Go to the Ligand Summary Page
Show all pathways known for 6.3.2.2Display the word mapDisplay the reaction diagram Show all sequences 6.3.2.24-Methylene glutamate no inhibition Go to the Ligand Summary Page
Results 1 - 10 of 194 > >>
download as CSV
download all results as CSV